CE:NYE-Celanese Corporation (USD)

COMMON STOCK | Chemicals |

Last Closing

USD 58.52

Change

+0.55 (+0.95)%

Market Cap

N/A

Volume

2.10M

Analyst Target

USD 110.50
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
HUN Huntsman Corporation

-0.22 (-1.25%)

USD 2.94B
BAK Braskem SA Class A

-0.10 (-2.51%)

USD 2.22B
TROX Tronox Holdings PLC

-0.02 (-0.27%)

USD 1.12B
WLKP Westlake Chemical Partners LP

+0.06 (+0.26%)

USD 0.82B
ASIX AdvanSix Inc

-0.63 (-2.61%)

USD 0.64B
VHI Valhi Inc

-0.36 (-2.01%)

USD 0.48B
RYAM Rayonier Advanced Materials

-0.13 (-2.38%)

USD 0.36B
LXU Lsb Industries Inc

+0.02 (+0.28%)

N/A
DOW Dow Inc

+0.10 (+0.27%)

N/A
REX REX American Resources Corpora..

-0.31 (-0.85%)

N/A

ETFs Containing CE

PUD.B:CA 1.88 % 0.66 %

N/A

N/A
HRES:CA 0.00 % 1.50 %

N/A

N/A
WNDY:LSE Global X Wind Energy UCIT.. 0.00 % 0.00 %

+0.04 (+0.41%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.45% 45% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.45% 45% F 11% F
Trailing 12 Months  
Capital Gain -63.91% 9% A- 2% F
Dividend Return 1.30% 14% F 24% F
Total Return -62.61% 9% A- 2% F
Trailing 5 Years  
Capital Gain -8.32% 18% F 15% F
Dividend Return 20.24% 29% F 46% F
Total Return 11.92% 9% A- 16% F
Average Annual (5 Year Horizon)  
Capital Gain 9.40% 36% F 63% D
Dividend Return 11.53% 27% F 63% D
Total Return 2.13% 38% F 49% F
Risk Return Profile  
Volatility (Standard Deviation) 41.62% 64% D 23% F
Risk Adjusted Return 27.70% 36% F 41% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.